☰

Valerie Trapp, Ph.D. - Publications

Affiliations: 
2009 Biomedical Engineering - Ph.D. University of California, Irvine, Irvine, CA 
Area:
Biomedical Engineering
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Hartmann EM, Beà S, Navarro A, Trapp V, Campo E, Ott G, Rosenwald A. Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expression. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 25: 1227-35. PMID 22555177 DOI: 10.1038/modpathol.2012.84  0.311
2011 Parmakhtiar B, Trapp V, Mossavat M, Eng M, Harris M. Abstract 2533: Synergistic interactions between topotecan and resveratrol in melanoma Cancer Research. 71: 2533-2533. DOI: 10.1158/1538-7445.Am2011-2533  0.617
2010 Trapp V, Parmakhtiar B, Papazian V, Willmott L, Fruehauf JP. Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture. Angiogenesis. 13: 305-15. PMID 20927579 DOI: 10.1007/S10456-010-9187-8  0.533
2009 Trapp V, Lee K, Doñate F, Mazar AP, Fruehauf JP. Redox-related antimelanoma activity of ATN-224. Melanoma Research. 19: 350-60. PMID 22760066 DOI: 10.1097/Cmr.0B013E32832C6324  0.64
2008 Fruehauf JP, Trapp V. Reactive oxygen species: an Achilles' heel of melanoma? Expert Review of Anticancer Therapy. 8: 1751-7. PMID 18983235 DOI: 10.1586/14737140.8.11.1751  0.603
2008 Zhang M, Fu W, Prabhu S, Moore JC, Ko J, Kim JW, Druker BJ, Trapp V, Fruehauf J, Gram H, Fan HY, Ong ST. Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance. Molecular and Cellular Biology. 28: 6496-509. PMID 18694961 DOI: 10.1128/Mcb.00477-08  0.586
2006 Doñate F, Juarez J, Maunia M, Burnett M, Trapp V, Fruehaut J, Mazar A. 411 POSTER SOD1 inhibition by tetrathiomolybdate demonstrates differential sensitivity against melanoma cell lines in vitro and in vivo: a possible method for identifying patients most likely to benefit from the second generation tetrathiomolybdate, ATN-224 European Journal of Cancer Supplements. 4: 126. DOI: 10.1016/S1359-6349(06)70416-5  0.318
Show low-probability matches.